GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAllergy Thera. Share News (AGY)

Share Price Information for Allergy Thera. (AGY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.20
Bid: 5.10
Ask: 5.30
Change: -0.05 (-0.95%)
Spread: 0.20 (3.922%)
Open: 5.20
High: 5.30
Low: 5.20
Prev. Close: 5.25
AGY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Finsbury Food's Annual Revenue Set To Fall

Wed, 15th Jul 2020 11:47

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Finsbury Food Group PLC - bakery and food service firm - Expects annual revenue to be GBP306.3 million, down from GBP315.3 million, due to declines in UK Bakery and Overseas division. First half revenue grew by 4.7% to GBP159.4 million, but second half was affected by Covid-19, with revenue falling by 9.8% to GBP146.9 million

----------

Open Orphan PLC - pharmaceutical services - Signs option to acquire CHIMagents Ltd for nominal sum. CHIMagents recently established to assist in design and manufacture of challenge agents for use in challenge studies. Open Orphan has three months to exercise the option.

----------

Air Partner PLC - aviation services - Security business Redline appointed to develop and deliver security management system for ISS Australia & New Zealand. ISS is a facility services provider, which provides security, screening and facility services across airports and ports. Trading remains ahead of budget with underlying pretax profit of GBP10 million in the first five months of 2020.

----------

Cambridge Cognition Holdings PLC - brain health firm based in Cambridge - Collaborates with 4YouandMe and Center for International Emergency Medical Services to investigate use of wearables and mobile phones to measure stress recovery in health works in the US caring for Covid-19 positive patients. Virtual study to take place over six months with up to 500 participants.

----------

Destiny Pharma PLC - Brighton-based biotechnology firm - Notes launch of USD1 billion AMR Action Fund to provide financial resources and technical support to help biotechnology companies bring novel anti-infective drugs to patients.

----------

Kodal Minerals PLC - mineral exploration and development - Signs USD1.5 million unsecured convertible loan agreement with Riverfort Global Opportunities PCC and YAII PN Ltd, which will allow for the continued development of its flagship Bougouni lithium project in Mali, and its gold projects in Mali and the Ivory Coast.

----------

Woodbois Ltd - Africa-focused timber producer - Raises GBP13.1 million through placing, retail offer and subscription of 655.0 million shares at a price of 2.0 pence per share, which will go towards expanding its production capacity and margins in Gabon, as well as grow its trading activities worldwide. Intends to pay dividend at end of 2021 financial year.

----------

Premier African Minerals Ltd - southern Africa-focused miner - Ministry of Industry, Commerce & Enterprise Development confirms that National Indigenisation & Economic Development Fund-appointed directors at RHA Tungsten Pvt Ltd can continue to act in their capacity. This removes one obstruction to finding a mutually acceptable solution to RHA's funding and equity dilemma.

----------

Caspian Sunrise PLC - oil & gas exploration - All Kazakh regulatory and shareholder approvals have been received, and relevant paperwork sent to UAE to complete the required re-registration of ownership of the Caspian Explorer, allowing for the acquisition of the asset.

----------

Allergy Therapeutics PLC - Sussex-based biotechnology firm - Expects earnings to be ahead of market expectations For year ended June 30. Revenue set to be GBP78.2 million, up 6% from GBP73.7 million. To repay all UK furlough monies claimed back to the government. Grass MATA MPL clinical programme expected to start next month as planned.

----------

AFC Energy PLC - hydrogen power generation technology developer - Forms collaboration with electric international rally series Extreme E to supply hydrogen fuelled, off-grid power for electric SUV racing due to start in early 2021.

----------

Carr's Group PLC - agriculture and engineering firm - For 19-week period ended July 11, trading remains in line with management expectations for financial year ending August 29. Agriculture division ahead of expectations, but Engineering unit affected by temporary interruptions to nuclear and defence projects. To pay interim dividend of 2.25p per share on October 2.

----------

BATM Advanced Communications Ltd - Israel-based data and telecommunications company - Develops three new test kits for Covid-19. Serologic test upgraded to measure quantity of antibodies in blood instead of just presence or absence. Antigen test upgraded to detect spike S gene to allow for diagnosis of Covid-19 in people with low viral loads. New molecular diagnostics test to identify specific respiratory virus. Sales and production to begin at start of fourth quarter of 2020.

----------

Mission Group PLC - creative agency - Expects revenue for first half of 2020 to be GBP29 million, down from GBP39 million the year before. Anticipates pretax loss of GBP2.2 million in interim period versus profit of GBP3.4 million. However, for 2020 as a whole, expects to deliver a profitable performance but at lower levels than 2019.

----------

Alpha FX Group PLC - currency risk management and payments - For first half of 2020, revenue increased by 16% to GBP18.0 million from GBP15.6 million, as average revenue per client rose with net increase of 28 clients to 671. Continues to invest in back office headcount and graphic expansion despite challenging environment.

----------

Bezant Resources PLC - operator of Kalengwa copper-gold project in Zambia and Hope copper-gold project in Namibia - Due diligence on Hope project progressing as planned, with combined mineral resource of 10.2 million tonnes at 1.9% copper and 0.3 grams per tonne of gold. From metallurgical test work, excellent recoveries made of 96% copper and 84% gold to a 28% copper grade.

----------

Portmeirion Group PLC - homewares manufacturer and distributor based in Stoke-on-Trent - Sales for six months to June to be down 8% at GBP32 million from GBP34.9 million. Like-for-like sales down 20%, excluding sales from Nambe division acquired in July 2019. Expects to report low single million pound pretax loss compared to profit of GBP500,000.

----------

Real Estate Investors PLC - Midlands-focused real estate investment trust - Rent collection for quarter to the end of June rises to 90.2% from 81% reported on June 15. Meanwhile rent collection for quarter ending September is 82% so far. Expects to pay 0.5 pence per share dividend on July 24.

----------

SEC Newgate Spa - communications, advocacy and research - Launches TRUE, an AI-powered platform to run new-to-market semantic and reputation assessments. Initially function in Italian, but can work five other languages, including English, French, German and Spanish. English version expected to be available in fourth quarter of 2020.

----------

Hydrogen Group PLC - recruitment firm - For the first six months of 2020, net fee income at GBP11.7 million, down from GBP15.3 million, as Covid-19 pandemic impacted client demand from Asia Pacific in January, which spread to its EMEA and US businesses over time.

----------

Arcontech Group PLC - market data software firm - Profit for year to the end of June set to be in line with market expectations, while net cash as at June 30 is GBP5.0 million, up from GBP4.1 million.

----------

GCP Asset Backed Income Fund Ltd - Asset backed loans investor - Net asset value per share as at June 30 was 100.83 pence. Will continue to keep in place discount rate movements on loans made to different investments due to continued uncertainty from Covid-19 pandemic.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
25 Sep 2019 11:26

Allergy Therapeutics Looking To Chinese Market As It Swings To Profit

Allergy Therapeutics Looking To Chinese Market As It Swings To Profit

Read more
27 Jun 2019 10:07

Allergy Therapeutics earnings set to top expectations

(Sharecast News) - Biotechnology group Allergy Therapeutics told investors on Thursday that 2019 full-year earnings looked set to come in ahead of market expectations.

Read more
19 Jun 2019 13:39

Allergy Therapeutics Hires Former Advanced Medical Solutions CFO

(Alliance News) - Allergy Therapeutics PLC on Wednesday said it has appointed Mary Tavener as a non-executive director with immediate effect.The biotechnology company said Tavener has in 19

Read more
20 May 2019 13:42

Allergy Therapeutics Vaccine Helps Dust Mite Allergy Symptoms In Study

LONDON (Alliance News) - Allergy Therapeutics PLC on Monday said its Acarovac MPL vaccine improved dust mite allergy symptoms during a phase one study.The AM101 study, which was open-label

Read more
20 May 2019 11:00

Allergy Therapeutics flags positive outcomes from recent treatment trial

(Sharecast News) - Biotechnology company Allergy Therapeutics announced positive Phase 1 safety and tolerability results of subcutaneous 'Acarovac MPL' (monophosphoryl lipid A) in patients with house dust mite-induced allergic rhinoconjunctivitis on Monday.

Read more
25 Apr 2019 10:01

Allergy Therapeutics eyes 2020 start for hay fever inoculation trials

(Sharecast News) - Commercial biotechnology company Allergy Therapeutics will kick off phase III trials of its short-course inoculation for grass pollen-induced hay fever in the second half of 2020 following a successful round of meetings with German and American regulatory bodies.

Read more
18 Mar 2019 10:44

WINNERS & LOSERS SUMMARY: Footasylum Rises On "Generous" JD Offer

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - Tinto, up 2.3%, Group, up in

Read more
18 Mar 2019 10:06

Allergy Therapeutics Surprised As Vaccine Trial Fails Primary Endpoint

LONDON (Alliance News) - Allergy Therapeutics PLC on Monday said a phase three trial of its birch pollen allergy vaccine did not meet its primary endpoint.Shares in Allergy Therapeutics 43%

Read more
18 Mar 2019 08:51

Allergy Therapeutics shares plunge after disappointing clinical trial

(Sharecast News) - Shares in biotechnology company Allergy Therapeutics were plunging on Monday morning, after it announced disappointing top-line results from the phase 3 clinical trial 'B301' of its new adjuvanted birch allergoid product.

Read more
6 Mar 2019 11:13

Allergy Therapeutics Interim Profit Rises 67% On Higher Revenue

LONDON (Alliance News) - Allergy Therapeutics PLC on Wednesday reported significantly higher profit for the first six months of its financial year as revenue rose and research costs were the to of

Read more
6 Mar 2019 10:19

Allergy Therapeutics profits rise as it spends less on R&D

(Sharecast News) - Specialty pharmaceutical group Allergy Therapeutics announced its unaudited interim results for the six months ended 31 December on Wednesday, reporting a 10.6% improvement in revenue on both a reported and constant currency basis, to £46.7m.

Read more
16 Jan 2019 12:26

Allergy Therapeutics First Half Meets Forecasts On European Growth

LONDON (Alliance News) - Allergy immunology vaccines developer Allergy Therapeutics PLC said Wednesday trading in the first half was in line with expectations.Allergy Therapeutics expects -

Read more
16 Jan 2019 08:51

Allergy Therapeutics sees good first-half progress

(Sharecast News) - Commercial biotechnology company Allergy Therapeutics updated the market for the six months ended 31 December on Wednesday, reporting that it was trading in line with board expectations.

Read more
27 Nov 2018 13:12

Allergy Therapeutics Continues To Perform Well, Revenue Up "Strongly"

LONDON (Alliance News) - Allergy Therapeutics PLC said Tuesday it has continued to perform well, with revenue up "strongly" from the prior year and sales in line with market financial to

Read more
27 Nov 2018 10:05

Allergy Therapeutics boosted by strong German performance

(Sharecast News) - Biotechnology company Allergy Therapeutics has seen revenues increase throughout the first half of its trading year thanks to an improved market share for its allergy vaccines on the continent.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.